SCHEMBL6002328

SCHEMBL6002328

FC(F)(F)C(F)(F)C(F)(F)c1ccccc1[S]

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2096793 0.86 ALDH1A1 (0.31) —
SCHEMBL28256785 0.83 ELANE (0.36) ELANE
SCHEMBL8846995 0.75 MAPT (0.35) ELANE
SCHEMBL2048302 0.75 ALDH1A1 (0.43) —
SCHEMBL13615442 0.74 KCNN4 (0.37) ELANE
SCHEMBL28730692 0.73 LMNA (0.39) ELANE
SCHEMBL6003031 0.73 ELANE (0.35) ELANE
SCHEMBL6279751 0.73 SMN1; SMN2 (0.39) ELANE
SCHEMBL6265278 0.73 ALDH1A1 (0.48) ELANE
SCHEMBL18242624 0.73 ELANE (0.32) ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 — — EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 — — WO disclosed
Send feedback